心房颤动心肌NF—κB的表达(2)
第1页 |
参见附件。
[参考文献]
[1] Savelieva I,Camm J. Update on arial fibrillation:Part I[J]. Clin Cardiol,2008,31:55-62.
[2] Kannel WB,Benjamin EJ. Status of the epidemiology of atrial fibrillation[J]. Med Clin North Am,2008,92:17-40.
[3] Issac TT,Dokainish H,Lakkis NM. Role of inflammation ininitiation and perpe tuation of atrial fibrillation:A systematic review of the published data[J]. J Am Coll Cardiol,2007,50:20-21.
[4] Engelmann MD,Svendsen JH. Inflammation in the genesisand perpetuation of atrial fibrillation[J]. Eur Heart J,2005,26:83-92.
[5] Chung MK,Martin DO,Sprecher D,et al. C- reactive protein elevation in patients with atrial arrhythmias:Inflammatory mechanisms and persistence of atrial fibrillation[J]. Circulation,2001,14:86-91.
[6] Jacobs MD,Harrison SC. Structure of an IkappaBalpha/NFkappaB complex[J]. Cell,1998,95:49-58.
[7] Von LD,Kockskj MJ,Rubertus SU,et al. Direct proarrhythmo-genie effects of angiotensin lI can be suppressed by AT1 receptor blockade in human atrial myocardium[J]. Eur J Heart Fail,2008,10(12):72-76.
[8] Ortego M,Bustos C,Hernandez-Presa MA,et al. Atorvastatin reduces NF-kappaBactivation and chemokine expression in vascular smooth muscle cells and mononuclear cells[J]. Atherosclerosis,1999,147:53-61.
[9] Young-Xu Y,Jabbour S,Goldberg R,et al. Usefulness of statin drugs in protecting against atrial fibrillation in patients with coronary artery disease[J]. Am J Cardiol,2003,92:79-83.
[10] Hitoshi Ichiki(MD)a. The role of infection in the development of non- valvular atrial fibrillation:Up-regulation of Toll-like receptor 2 expression levels on monocytes[J]. Journal of Cardiology,2011,53:27-35.
[11] Aviles RJ,Martin DO,Apperson-Hansen C,et al. Inflammation as a risk factor for atrial fibrillation[J]. Circulation,2003,18:6-10.
[12] Qu YC,Du YM. Activated nuclear factor-kB and increased tumor necrosis factor-a in atrial tissue of atrial fibrillation[J]. Scandinavian Cardiovascular Journal,2010,43:92-97.
(收稿日期:2012-09-10)
您现在查看是摘要介绍页,详见PDF附件(2816kb)。